Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Registry Study of Genetic Profiling and Targeted Therapies in Patients With Rare Cancers in ASIA

NCT05217407 is registered in ClinicalTrials.gov with National Cancer Center, Japan as lead sponsor.

NCT NCT05217407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05217407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Registry Study of Genetic Profiling and Targeted Therapies in Patients With Rare Cancers in ASIA
Lead sponsor
National Cancer Center, Japan
Phase
Observational
Overall status
Recruiting
Start date
November 30, 2021
Completion date
March 31, 2030
Enrollment
1,000 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

rare malignant neoplasm